Status:

RECRUITING

Re-Engaging AYA Survivors in Cancer-Related Healthcare

Lead Sponsor:

Children's Hospital of Philadelphia

Collaborating Sponsors:

Nationwide Children's Hospital

University of Pennsylvania

Conditions:

Cancer

Eligibility:

All Genders

15-29 years

Phase:

NA

Brief Summary

The goal of this clinical trial is to test the efficacy (how well they work) of different digital interventions that deliver information to adolescent and young adult (AYA) survivors of childhood canc...

Detailed Description

Over 80% of children diagnosed with cancer become long-term survivors; however, 70% develop chronic or life-threatening late effects from treatment, and these often emerge during young adulthood. Guid...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for AYA
  • 15-29 years old
  • History of a childhood cancer diagnosis, diagnosed prior to age 22
  • Has not had a cancer-related follow-up visit in at least 15 months (or is 3 months past recommended follow-up)
  • U.S. resident (not international patient)
  • Has previously attended a cancer-related appointment at Children's Hospital of Philadelphia, or Nationwide Children's Hospital or Penn
  • At least 2 years from end of treatment and 5 years from diagnosis
  • English proficient
  • For AYA under age 18, must have a caregiver to provide informed consent
  • Exclusion Criteria for AYA
  • Cognitive impairment limiting participation
  • Received surgery only treatment
  • Transferred to primary care
  • Currently living with cancer diagnosis (either new, metastatic, recurrence, or relapse)
  • Absence of documentation of treatment history
  • Absence of inclusion criteria above
  • Inclusion Criteria for Support Person of AYA
  • Primary caregiver or other support person (e.g. partner, sibling, other caregiver)
  • At least 18 years old
  • U.S. resident
  • English proficient
  • Exclusion Criteria for Support Person of AYA
  • No involvement in the AYA's healthcare
  • AYA Decline support person's participation
  • Absence of inclusion criteria above

Exclusion

    Key Trial Info

    Start Date :

    August 1 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    April 30 2028

    Estimated Enrollment :

    530 Patients enrolled

    Trial Details

    Trial ID

    NCT07138040

    Start Date

    August 1 2025

    End Date

    April 30 2028

    Last Update

    September 10 2025

    Active Locations (3)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (3 locations)

    1

    Nationwide Children's Hospital

    Columbus, Ohio, United States, 43205

    2

    Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania, United States, 19104

    3

    Penn Medicine

    Philadelphia, Pennsylvania, United States, 19104